Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | HTR2B | P41595 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13580007 | 0.91 | TSHR (0.35) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL19905522 | 0.85 | FAAH (0.38) | — | |
| SCHEMBL4214037 | 0.83 | GABRA1 (0.45) | — | |
| SCHEMBL4578438 | 0.82 | GABRA1 (0.47) | — | |
| Hydrochloric Acid SCHEMBL942566 | 0.80 | GABRA1 (0.45) | — | |
| SCHEMBL22708713 | 0.77 | TYR (0.39) | LMNACHRM1ADRA1A | |
| SCHEMBL126196 | 0.77 | GABRA1 (0.43) | LMNASLC6A2HTR2B | |
| SCHEMBL29021832 | 0.76 | GABRA1 (0.39) | LMNASLC6A2HTR2B | |
| SCHEMBL17120959 | 0.75 | LMNA (0.32) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| Hydrochloric Acid SCHEMBL360317 | 0.75 | GABRA1 (0.41) | LMNASLC6A2HTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117658963-A | Diastereoisomers of vitamin C derivatives, preparation and application thereof | 上海克琴科技有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-20170170420-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | CANON KABUSHIKI KAISHA (JP) | 2017-06-15 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
| US-20120004430-A1 | PRODUCTION OF HYDROXYMETHYLFURFURAL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-01-05 | — | — | US | disclosed |
| US-20120004430-A1 | PRODUCTION OF HYDROXYMETHYLFURFURAL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | WEE1, WEE2, THEM6 | LMNA 3453/4885TRPA1 2475/4885CHRM1 2326/4885 |
| US-20120004430-A1 | PRODUCTION OF HYDROXYMETHYLFURFURAL | FBP1, G6PD, UGDH | LMNA 4800/4885TRPA1 4740/4885CHRM1 3890/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.